31 results
8-K
EX-1.1
APLS
Apellis Pharmaceuticals Inc
1 Nov 23
Entry into a Material Definitive Agreement
7:59am
funding standards of Section 302 of the United States Employee Retirement Income Security Act of 1974, as amended (“ERISA”), and the regulations … -retirement benefit obligations” (within the meaning of Statement of Financial Accounting Standards 106) of the Company and its subsidiaries compared
8-K
EX-1.1
ze8 gid6j9
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm
8-K
EX-1.1
t0w sqelx
20 Jan 22
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
njx9y8qini4pmvb
17 Nov 21
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9:04am
8-K
EX-10.1
t29fx48cbdbv9d59ry
7 May 20
Apellis Pharmaceuticals Announces Private Placement of Convertible Senior Notes
7:44am
S-8
ww7 ybeid2a
27 Feb 20
Registration of securities for employees
12:00am
S-8
pceml1way
27 Feb 20
Registration of securities for employees
12:00am
8-K
EX-1.1
h4g7lbm0x7 r7g4ilm
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
S-3ASR
EX-4.3
g1q8u
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.4
qghp0s4
7 Jan 20
Automatic shelf registration
4:01pm
8-K
EX-10.1
knnsns
7 Oct 19
Departure of Directors or Certain Officers
4:06pm
POS AM
EX-1.2
5i1o16 24jkbhw
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
8-K
EX-10.1
x2g5ccfjycvdfmp3yq
16 Sep 19
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
5:17pm